Home / Pharmaceutical company intelligence
Sante (Private) Limited logo
Pharmaceutical company intelligence

Sante (Private) Limited

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi specialty pharmaceutical manufacturer established in 1996 with strong ophthalmology, dermatology, ENT and general-medicine portfolios.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Private pharmaceutical manufacturer
Address
39-C/1, Block 6, P.E.C.H.S., Karachi 75400, Pakistan · 75400
Phone
+92 21 38679761-64
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000702 Sante (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000702 55 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx55public portfolio records represented
REG50unique registrations represented
IDX41indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR51current validated price records
G29generic molecules in indexed catalogue
DF9dosage-form groups
TA7therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage93%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSante (Private) LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sante-private-limitedGenerated 23 Sep 2026Anti-infectives42 · 76%Ophthalmology5 · 9%Dermatology2 · 4%Cardiovascular2 · 4%Gastrointestinal & hepatology2 · 4%Cross-therapeutic & anti-inflamma…1 · 2%Respiratory & allergy1 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSante (Private) LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sante-private-limitedGenerated 23 Sep 202655presentationsTablet20 · 36%Capsule9 · 16%Drops8 · 15%Cream6 · 11%Solution5 · 9%Ointment3 · 5%Other forms4 · 7%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSante (Private) LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sante-private-limitedGenerated 23 Sep 202648comparable productsBelow peer median10 · 21%Near peer median10 · 21%Above peer median28 · 58%Company median price position+6.4%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSante (Private) LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/sante-private-limitedGenerated 23 Sep 2026Atco Laboratories Limited20 shared69% overlapValor Pharmaceuticals20 shared69% overlapEpharm Laboratories20 shared69% overlapPharmasol (Pvt) Ltd.19 shared66% overlapNabiqasim Industries (Pvt) Ltd.,18 shared62% overlapPearl Pharmaceuticals18 shared62% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives42 products · 76%
Ophthalmology5 products · 9%
Dermatology2 products · 4%
Cardiovascular2 products · 4%
Gastrointestinal & hepatology2 products · 4%
Cross-therapeutic & anti-inflammatory1 products · 2%
Respiratory & allergy1 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluoroquinolone antibacterials14 products · 25%
Macrolide antibacterials6 products · 11%
Antimalarials6 products · 11%
Antifungals6 products · 11%
Antivirals5 products · 9%
Glaucoma medicines4 products · 7%
Topical corticosteroids / anti-inflammatory dermatologics2 products · 4%
Calcium-channel blockers2 products · 4%
Formulation footprint

Dosage forms

Tablet20 products
Capsule9 products
Drops8 products
Cream6 products
Solution5 products
Ointment3 products
Suspension2 products
Lotion1 products
Spray1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 Otoflox EarOfloxacin 4presentations 0.3 %, 0.6 % · Drops #2 SanflucanFluconazole 3presentations 150 mg, 200 mg, 50 mg · Capsule #3 ZithrosanAzithromycin 3presentations 250 mg, 500 mg · Capsule, Tablet #4 Betalol EyeTimolol 2presentations 5.0 mg, 5.0 mg/mL · Solution #5 ClarazeClarithromycin 2presentations 250 mg, 500 mg · Tablet #6 FloxasanLevofloxacin 2presentations 250 mg, 500 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1021% of comparable products
Near market median10within ±5% of median
Above market median2858% of comparable products
Lowest-price equivalents1ties included
Company median price position +6.4% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Vislat 50 mcg/mLLatanoprost · Ophthalmic drops · 2.5ml PKR 353.27/mL-46.1% vs market median Permisan 5%Permethrin · Cream · 30gm PKR 2.75/g-29.4% vs market median Sanzole Skin 10 mgClotrimazole · Cream · 10gm PKR 6.82/g-22.3% vs market median Quilinol 250 mgChloroquine · Tablet · 500's PKR 1.23/tablet-21.4% vs market median Dipsan 10mg TabletEach 10 mgAmlodipine · Tablet · 20's PKR 15.67/tablet-11.8% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Atco Laboratories Limited278 products · 94 generics 20shared generics Valor Pharmaceuticals219 products · 97 generics 20shared generics Epharm Laboratories144 products · 67 generics 20shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 19shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 18shared generics Pearl Pharmaceuticals118 products · 46 generics 18shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers50Distinct registrations among indexed, published, presentation-validated products only
Verified price observations55
Products with a verified price55
Products with multiple price observations0
Source records with multiple versions55
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

50 unique registration(s) · 41 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Bakcin Ciprofloxacin 3 mg/mL Ophthalmic solution 5ml 030361 PKR 219.94 PKR 43.99/mL 22% above median
Claraze Clarithromycin 250 mg Tablet 10's 073446 PKR 526.21 PKR 52.62/tablet 11% above median
Claraze Clarithromycin 500 mg Tablet 10's 073447 PKR 919.08 PKR 91.91/tablet 10% above median
Floxasan Levofloxacin 250 mg Tablet 10's 090929 PKR 485.37 PKR 48.54/tablet Near median
Floxasan Levofloxacin 500 mg Tablet 10's 090930 PKR 807.65 PKR 80.77/tablet Near median
Hyoxlin Hydroxychloroquine 200 mg Tablet 50's 104419 PKR 675.31 PKR 13.51/tablet 7% below median
Hyoxlin Hydroxychloroquine 200 mg Tablet 30's 104419 PKR 405.19 PKR 13.51/tablet 7% below median
Lopnar 200 Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 104421 PKR 11,525.22 PKR 96.04/tablet Near median
Lumerax Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 073448 PKR 660.91 PKR 41.31/tablet 5% above median
Lumerax Forte Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 073449 PKR 578.85 PKR 72.36/tablet 13% above median
Lumerax Forte Artemether + Lumefantrine 40 mg + 240 mg Tablet 10's 073449 PKR 679.65 PKR 67.97/tablet 6% above median
Megamox Moxifloxacin 200 mg Tablet 10's 039285 PKR 484.33 PKR 48.43/tablet 16% above median
Natasan Natamycin 50.0 mg/mL Suspension 5ml 024659 PKR 408.35 PKR 81.67/mL No comparator
Optoflox Ofloxacin 3 mg/mL Ophthalmic solution 5ml 007501 PKR 168.44 PKR 33.69/mL Near median
Optoflox Ofloxacin 0.3% Ophthalmic ointment 3.5gm 021608 PKR 195.12 PKR 55.75/g 40% above median
Otoflox Ear Ofloxacin 0.3 % Ear drops 5ml 026137 PKR 161.93 PKR 32.39/mL 18% above median
Otoflox Ear Ofloxacin 0.3 % Ear drops 10ml 026137 PKR 273.63 PKR 27.36/mL 9% below median
Otoflox Ear Ofloxacin 0.6 % Ear drops 5ml 026138 PKR 273.63 PKR 54.73/mL 15% above median
Otoflox Ear Ofloxacin 0.6 % Ear drops 10ml 026138 PKR 478.85 PKR 47.89/mL 6% below median
Permisan Permethrin 5% Lotion 60ml 061886 PKR 170.61 PKR 2.84/mL Near median
Permisan Permethrin 5% Cream 30gm 061887 PKR 82.59 PKR 2.75/g 29% below median
Prolotic Otic Ciprofloxacin 0.3 % Ear drops 5ml 073452 PKR 196.21 PKR 39.24/mL Near median
Quilinol Chloroquine 250 mg Tablet 500's 104420 PKR 615.43 PKR 1.23/tablet 21% below median
Sanflucan Fluconazole 50 mg Capsule 7's 086044 PKR 916.28 PKR 130.90/capsule 6% above median
Sanflucan Fluconazole 200 mg Capsule 4's 086046 PKR 1,004.79 PKR 251.20/capsule 13% above median
Sanflucan Fluconazole 150 mg Capsule 1's 088917 PKR 282.92 PKR 282.92/capsule 8% above median
Santobrex Tobramycin 3 mg/mL Ophthalmic solution 5ml 026912 PKR 223.31 PKR 44.66/mL No comparator
Santomox Moxifloxacin 400 mg Tablet 5's 037031 PKR 994.59 PKR 198.92/tablet 8% above median
Santosel Oseltamivir 75 mg Capsule 10's 104422 PKR 1,125.52 PKR 112.55/capsule 7% below median
Santovir Aciclovir 30 mg/g Ophthalmic ointment 4.5gm 023325 PKR 300.45 PKR 66.77/g 21% above median
Santovir Aciclovir 800 mg Tablet 10's 027081 PKR 2,104.83 PKR 210.48/tablet 194% above median
Santovir Skin Aciclovir 5 % Cream 10gm 027080 PKR 513.31 PKR 51.33/g 47% above median
Sanzole Skin Clotrimazole 10 mg Cream 10gm 030353 PKR 68.17 PKR 6.82/g 22% below median
Terbisan Terbinafine 10 mg Cream 10gm 027076 PKR 294.42 PKR 29.44/g Near median
Vibsan Doxycycline 50 mg Capsule 56's 067488 PKR 251.68 PKR 4.49/capsule 23% above median
Zeproquin Ciprofloxacin 250 mg Tablet 10's 076126 PKR 268.48 PKR 26.85/tablet 6% above median
Zeproquin Ciprofloxacin 500 mg Tablet 10's 076183 PKR 456.49 PKR 45.65/tablet 7% above median
Zithrosan Azithromycin 250 mg Capsule 10's 027079 PKR 582.11 PKR 58.21/capsule 18% above median
Zithrosan Azithromycin 500 mg Capsule 6's 037032 PKR 575.81 PKR 95.97/capsule 15% above median
Zithrosan Azithromycin 500 mg Tablet 6's 083766 PKR 599.24 PKR 99.87/tablet 18% above median
Zithrosan 1% Eye Azithromycin 1 % Ophthalmic drops 2.5ml 104067 PKR 199.60 PKR 79.84/mL 23% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Sante (Private) Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/sante-private-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.